Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multifactorial Inheritance | 23 | 2024 | 1426 | 4.730 |
Why?
|
Hyperlipoproteinemia Type II | 15 | 2024 | 394 | 4.660 |
Why?
|
Coronary Artery Disease | 49 | 2024 | 6544 | 4.420 |
Why?
|
Atherosclerosis | 23 | 2024 | 3421 | 2.890 |
Why?
|
Lipoprotein(a) | 8 | 2023 | 488 | 2.580 |
Why?
|
Cholesterol, HDL | 13 | 2023 | 1811 | 2.240 |
Why?
|
Cardiovascular Diseases | 39 | 2025 | 15645 | 2.160 |
Why?
|
Genome-Wide Association Study | 40 | 2024 | 12800 | 1.830 |
Why?
|
Coronary Disease | 14 | 2023 | 5923 | 1.700 |
Why?
|
Genetic Predisposition to Disease | 36 | 2024 | 18064 | 1.680 |
Why?
|
Hypercholesterolemia | 8 | 2024 | 1148 | 1.610 |
Why?
|
Genetic Variation | 14 | 2021 | 6607 | 1.420 |
Why?
|
Hypolipidemic Agents | 5 | 2023 | 608 | 1.340 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 11 | 2022 | 3251 | 1.310 |
Why?
|
Lipoproteins, HDL | 7 | 2023 | 674 | 1.300 |
Why?
|
Cholesterol, LDL | 20 | 2024 | 2393 | 1.230 |
Why?
|
Genome, Human | 8 | 2022 | 4445 | 1.030 |
Why?
|
Biological Specimen Banks | 9 | 2022 | 787 | 0.920 |
Why?
|
Diabetes Mellitus, Type 2 | 19 | 2024 | 12235 | 0.850 |
Why?
|
Niacin | 2 | 2014 | 116 | 0.840 |
Why?
|
Penetrance | 3 | 2023 | 388 | 0.830 |
Why?
|
Fluorobenzenes | 2 | 2014 | 179 | 0.790 |
Why?
|
Risk Factors | 64 | 2024 | 74853 | 0.790 |
Why?
|
Dyslipidemias | 4 | 2015 | 869 | 0.790 |
Why?
|
Humans | 176 | 2025 | 765823 | 0.730 |
Why?
|
Intra-Abdominal Fat | 2 | 2023 | 624 | 0.690 |
Why?
|
Hyperlipoproteinemia Type I | 1 | 2019 | 9 | 0.680 |
Why?
|
Myocardial Infarction | 9 | 2023 | 11506 | 0.660 |
Why?
|
Heterozygote | 6 | 2020 | 2795 | 0.640 |
Why?
|
Apolipoproteins B | 4 | 2024 | 384 | 0.640 |
Why?
|
Disease | 3 | 2020 | 674 | 0.630 |
Why?
|
Middle Aged | 71 | 2025 | 223016 | 0.620 |
Why?
|
Cholesterol | 5 | 2022 | 2898 | 0.620 |
Why?
|
Lipoprotein Lipase | 3 | 2021 | 132 | 0.620 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 559 | 0.610 |
Why?
|
Receptors, LDL | 3 | 2023 | 491 | 0.580 |
Why?
|
Asymptomatic Diseases | 2 | 2022 | 584 | 0.580 |
Why?
|
Lipids | 9 | 2022 | 3316 | 0.570 |
Why?
|
Case-Control Studies | 22 | 2022 | 22227 | 0.560 |
Why?
|
Genetic Counseling | 1 | 2021 | 634 | 0.550 |
Why?
|
Apolipoprotein B-100 | 2 | 2024 | 157 | 0.550 |
Why?
|
Metabolic Diseases | 3 | 2022 | 687 | 0.540 |
Why?
|
Lipid Metabolism | 5 | 2021 | 1892 | 0.530 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1959 | 0.530 |
Why?
|
Obesity | 14 | 2024 | 13078 | 0.530 |
Why?
|
Male | 79 | 2025 | 363740 | 0.520 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1339 | 0.520 |
Why?
|
Polymorphism, Single Nucleotide | 23 | 2023 | 16040 | 0.510 |
Why?
|
Drug Utilization | 1 | 2022 | 1187 | 0.510 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 388 | 0.500 |
Why?
|
Female | 79 | 2025 | 396050 | 0.500 |
Why?
|
Heptanoic Acids | 2 | 2015 | 344 | 0.500 |
Why?
|
Pravastatin | 2 | 2015 | 391 | 0.500 |
Why?
|
Aged | 44 | 2025 | 171178 | 0.490 |
Why?
|
Propionates | 1 | 2015 | 180 | 0.470 |
Why?
|
Cholesterol Ester Transfer Proteins | 2 | 2017 | 111 | 0.460 |
Why?
|
Resistin | 1 | 2015 | 174 | 0.460 |
Why?
|
Acute Coronary Syndrome | 4 | 2022 | 2184 | 0.460 |
Why?
|
DNA | 4 | 2023 | 7197 | 0.460 |
Why?
|
Sulfonamides | 2 | 2014 | 1981 | 0.460 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1024 | 0.460 |
Why?
|
Fenofibrate | 1 | 2014 | 86 | 0.450 |
Why?
|
Risk Assessment | 21 | 2024 | 24278 | 0.450 |
Why?
|
Triglycerides | 8 | 2019 | 2441 | 0.450 |
Why?
|
PPAR alpha | 1 | 2015 | 176 | 0.450 |
Why?
|
Proprotein Convertases | 1 | 2014 | 95 | 0.440 |
Why?
|
Benzodiazepines | 1 | 2020 | 1135 | 0.430 |
Why?
|
Genetic Testing | 6 | 2022 | 3590 | 0.430 |
Why?
|
Death, Sudden, Cardiac | 3 | 2022 | 1567 | 0.430 |
Why?
|
Genomics | 5 | 2022 | 5926 | 0.420 |
Why?
|
Atrial Fibrillation | 5 | 2022 | 5187 | 0.410 |
Why?
|
Pyrimidines | 2 | 2014 | 3047 | 0.380 |
Why?
|
Thrombocytopenia | 1 | 2019 | 1171 | 0.380 |
Why?
|
Phenotype | 20 | 2024 | 16706 | 0.380 |
Why?
|
Hemorrhage | 2 | 2021 | 3464 | 0.380 |
Why?
|
Pyrroles | 2 | 2015 | 1119 | 0.370 |
Why?
|
Life Style | 3 | 2024 | 3929 | 0.370 |
Why?
|
Body Weight | 2 | 2019 | 4624 | 0.370 |
Why?
|
Body Mass Index | 10 | 2024 | 13041 | 0.360 |
Why?
|
Foam Cells | 1 | 2011 | 67 | 0.360 |
Why?
|
Adult | 37 | 2025 | 223055 | 0.330 |
Why?
|
Triazoles | 1 | 2015 | 897 | 0.330 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 2771 | 0.330 |
Why?
|
Myocarditis | 3 | 2022 | 801 | 0.330 |
Why?
|
Heart Failure | 4 | 2022 | 11838 | 0.320 |
Why?
|
Biological Transport | 3 | 2011 | 2082 | 0.320 |
Why?
|
Aspirin | 1 | 2021 | 3135 | 0.320 |
Why?
|
Holistic Health | 1 | 2008 | 47 | 0.310 |
Why?
|
Health Status Disparities | 1 | 2020 | 1879 | 0.300 |
Why?
|
Stroke | 8 | 2023 | 9749 | 0.300 |
Why?
|
Hypertension | 5 | 2023 | 8625 | 0.300 |
Why?
|
Anticholesteremic Agents | 2 | 2020 | 970 | 0.300 |
Why?
|
Mutation | 9 | 2023 | 30188 | 0.300 |
Why?
|
Macrophages | 3 | 2013 | 5771 | 0.300 |
Why?
|
Adipose Tissue | 4 | 2024 | 3314 | 0.300 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 8039 | 0.290 |
Why?
|
Primary Prevention | 5 | 2022 | 1187 | 0.290 |
Why?
|
Odds Ratio | 6 | 2020 | 9653 | 0.290 |
Why?
|
Genetics, Medical | 2 | 2021 | 334 | 0.290 |
Why?
|
Genotype | 10 | 2024 | 13023 | 0.280 |
Why?
|
Secondary Prevention | 3 | 2023 | 1471 | 0.280 |
Why?
|
Leptin | 1 | 2015 | 1597 | 0.280 |
Why?
|
Adiposity | 5 | 2023 | 1890 | 0.270 |
Why?
|
Carotid Artery Diseases | 1 | 2013 | 878 | 0.270 |
Why?
|
Mendelian Randomization Analysis | 6 | 2023 | 1039 | 0.270 |
Why?
|
Genetics, Population | 3 | 2021 | 943 | 0.270 |
Why?
|
Terminally Ill | 1 | 2008 | 240 | 0.270 |
Why?
|
Heart Diseases | 2 | 2021 | 2818 | 0.260 |
Why?
|
Fasting | 1 | 2012 | 1605 | 0.260 |
Why?
|
Cohort Studies | 16 | 2025 | 41643 | 0.260 |
Why?
|
Thrombolytic Therapy | 1 | 2015 | 2059 | 0.260 |
Why?
|
Eating | 1 | 2012 | 1538 | 0.250 |
Why?
|
Waist-Hip Ratio | 2 | 2017 | 520 | 0.250 |
Why?
|
Incidence | 9 | 2024 | 21501 | 0.250 |
Why?
|
Lipodystrophy, Familial Partial | 1 | 2024 | 5 | 0.240 |
Why?
|
Prospective Studies | 12 | 2025 | 54798 | 0.230 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26276 | 0.230 |
Why?
|
Lipoproteins | 2 | 2020 | 866 | 0.220 |
Why?
|
Obesity, Abdominal | 2 | 2017 | 370 | 0.220 |
Why?
|
Tobacco, Smokeless | 1 | 2025 | 132 | 0.220 |
Why?
|
Coronary Vessels | 6 | 2024 | 3096 | 0.210 |
Why?
|
Mutation, Missense | 3 | 2021 | 2586 | 0.210 |
Why?
|
Founder Effect | 1 | 2023 | 185 | 0.200 |
Why?
|
Hospitalization | 2 | 2020 | 10803 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3099 | 0.200 |
Why?
|
Polymorphism, Genetic | 3 | 2022 | 4249 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3222 | 0.200 |
Why?
|
Cholecystitis | 1 | 2023 | 181 | 0.200 |
Why?
|
Disease Management | 3 | 2022 | 2532 | 0.190 |
Why?
|
Bangladesh | 2 | 2023 | 745 | 0.190 |
Why?
|
Nutrition Therapy | 1 | 2023 | 101 | 0.190 |
Why?
|
Cholelithiasis | 1 | 2023 | 408 | 0.190 |
Why?
|
Drug Discovery | 1 | 2009 | 1063 | 0.190 |
Why?
|
Nitric Oxide | 2 | 2022 | 2143 | 0.180 |
Why?
|
Eye Hemorrhage | 1 | 2021 | 19 | 0.180 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 157 | 0.180 |
Why?
|
Electronic Health Records | 4 | 2022 | 4864 | 0.180 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8725 | 0.180 |
Why?
|
Calcium | 6 | 2024 | 5767 | 0.180 |
Why?
|
American Heart Association | 5 | 2024 | 1046 | 0.180 |
Why?
|
Atlases as Topic | 1 | 2022 | 247 | 0.180 |
Why?
|
Primary Health Care | 1 | 2017 | 4735 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 148 | 0.170 |
Why?
|
Primates | 1 | 2022 | 518 | 0.170 |
Why?
|
Scotland | 1 | 2020 | 141 | 0.170 |
Why?
|
Semen | 1 | 2022 | 353 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 151 | 0.160 |
Why?
|
Blood Pressure | 6 | 2023 | 8532 | 0.160 |
Why?
|
Factor XI | 1 | 2019 | 40 | 0.160 |
Why?
|
Coronary Angiography | 4 | 2024 | 4497 | 0.160 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12520 | 0.160 |
Why?
|
Elasticity Imaging Techniques | 1 | 2024 | 398 | 0.160 |
Why?
|
Chromosome Mapping | 3 | 2022 | 4618 | 0.160 |
Why?
|
Predictive Value of Tests | 8 | 2023 | 15398 | 0.160 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4772 | 0.160 |
Why?
|
Adipose Tissue, White | 1 | 2022 | 371 | 0.160 |
Why?
|
Photoplethysmography | 1 | 2019 | 66 | 0.160 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 401 | 0.160 |
Why?
|
Metagenomics | 1 | 2022 | 473 | 0.150 |
Why?
|
Hypertriglyceridemia | 1 | 2021 | 290 | 0.150 |
Why?
|
Immunization, Secondary | 1 | 2021 | 373 | 0.150 |
Why?
|
Linkage Disequilibrium | 5 | 2022 | 1996 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 820 | 0.150 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 133 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.150 |
Why?
|
Oxidoreductases | 1 | 2020 | 409 | 0.150 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1788 | 0.140 |
Why?
|
India | 2 | 2023 | 2333 | 0.140 |
Why?
|
Sweden | 1 | 2020 | 1381 | 0.140 |
Why?
|
Insulin Resistance | 3 | 2022 | 3987 | 0.140 |
Why?
|
Brain Ischemia | 2 | 2021 | 3001 | 0.140 |
Why?
|
Double-Blind Method | 3 | 2017 | 12421 | 0.140 |
Why?
|
Angiopoietins | 1 | 2017 | 86 | 0.130 |
Why?
|
Oligonucleotides | 1 | 2019 | 561 | 0.130 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2017 | 100 | 0.130 |
Why?
|
Risk | 2 | 2020 | 9600 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2022 | 1667 | 0.130 |
Why?
|
Body Height | 1 | 2022 | 1561 | 0.130 |
Why?
|
Blood Proteins | 1 | 2021 | 1186 | 0.130 |
Why?
|
Fingers | 1 | 2019 | 509 | 0.130 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2498 | 0.130 |
Why?
|
Myocardial Ischemia | 2 | 2019 | 2129 | 0.130 |
Why?
|
Prevalence | 3 | 2024 | 15832 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2023 | 840 | 0.130 |
Why?
|
Endothelin-1 | 1 | 2017 | 295 | 0.130 |
Why?
|
Blood Glucose | 5 | 2022 | 6422 | 0.130 |
Why?
|
Sequence Analysis | 1 | 2016 | 239 | 0.120 |
Why?
|
Patient Care | 1 | 2021 | 629 | 0.120 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 220 | 0.120 |
Why?
|
Students, Medical | 1 | 2008 | 1962 | 0.120 |
Why?
|
Pedigree | 2 | 2020 | 4528 | 0.120 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2016 | 174 | 0.120 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 810 | 0.120 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39226 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2022 | 1241 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2017 | 707 | 0.110 |
Why?
|
Databases, Factual | 3 | 2020 | 8062 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2020 | 975 | 0.110 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2741 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 844 | 0.110 |
Why?
|
Prognosis | 4 | 2020 | 29915 | 0.110 |
Why?
|
United States | 11 | 2025 | 72896 | 0.110 |
Why?
|
Apolipoprotein A-I | 1 | 2015 | 304 | 0.110 |
Why?
|
Apolipoprotein C-III | 1 | 2015 | 209 | 0.110 |
Why?
|
Fatty Liver | 1 | 2020 | 808 | 0.110 |
Why?
|
Biofeedback, Psychology | 1 | 2014 | 117 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1127 | 0.110 |
Why?
|
Gene Frequency | 4 | 2022 | 3623 | 0.110 |
Why?
|
Pandemics | 3 | 2024 | 8698 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10723 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2023 | 1465 | 0.100 |
Why?
|
Animals | 12 | 2023 | 168730 | 0.100 |
Why?
|
Vaccination | 2 | 2022 | 3425 | 0.100 |
Why?
|
Disease Progression | 2 | 2024 | 13613 | 0.090 |
Why?
|
Hypoglycemic Agents | 2 | 2017 | 3107 | 0.090 |
Why?
|
Proteome | 1 | 2021 | 1898 | 0.090 |
Why?
|
Nanoparticles | 1 | 2023 | 1967 | 0.090 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4041 | 0.090 |
Why?
|
Young Adult | 6 | 2024 | 59849 | 0.090 |
Why?
|
Lipase | 2 | 2024 | 320 | 0.090 |
Why?
|
Simvastatin | 1 | 2013 | 345 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2595 | 0.090 |
Why?
|
Exercise | 2 | 2024 | 5937 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20131 | 0.090 |
Why?
|
Chronic Disease | 2 | 2024 | 9355 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3802 | 0.090 |
Why?
|
Recurrence | 2 | 2015 | 8506 | 0.090 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2011 | 275 | 0.090 |
Why?
|
Qualitative Research | 1 | 2021 | 3135 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 805 | 0.090 |
Why?
|
Family | 1 | 2021 | 3208 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1327 | 0.080 |
Why?
|
Age of Onset | 1 | 2017 | 3341 | 0.080 |
Why?
|
Mental Health | 2 | 2022 | 3271 | 0.080 |
Why?
|
Constipation | 1 | 2014 | 568 | 0.080 |
Why?
|
Time Factors | 3 | 2020 | 40109 | 0.080 |
Why?
|
Wine | 1 | 2010 | 172 | 0.080 |
Why?
|
Placebos | 1 | 2013 | 1659 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2307 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7416 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 455 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2017 | 1164 | 0.080 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2010 | 277 | 0.080 |
Why?
|
Databases, Genetic | 3 | 2021 | 1751 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4257 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3909 | 0.080 |
Why?
|
Holocaust | 1 | 2008 | 37 | 0.080 |
Why?
|
Behavior Therapy | 1 | 2014 | 886 | 0.080 |
Why?
|
Hyperemia | 1 | 2010 | 224 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2743 | 0.070 |
Why?
|
Thiazolidinediones | 1 | 2011 | 459 | 0.070 |
Why?
|
Mice | 5 | 2022 | 81788 | 0.070 |
Why?
|
Famous Persons | 1 | 2008 | 108 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18380 | 0.070 |
Why?
|
Troponin T | 2 | 2023 | 785 | 0.070 |
Why?
|
Homozygote | 2 | 2023 | 1774 | 0.070 |
Why?
|
Flavonoids | 1 | 2010 | 446 | 0.070 |
Why?
|
Narration | 1 | 2008 | 223 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7840 | 0.070 |
Why?
|
Carotid Arteries | 1 | 2011 | 937 | 0.070 |
Why?
|
Patient Compliance | 1 | 2016 | 2693 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2023 | 1736 | 0.060 |
Why?
|
Phenols | 1 | 2010 | 522 | 0.060 |
Why?
|
Blood Pressure Determination | 1 | 2010 | 648 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10570 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 1312 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3656 | 0.060 |
Why?
|
Registries | 1 | 2022 | 8320 | 0.060 |
Why?
|
Child | 5 | 2024 | 80509 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2021 | 59506 | 0.060 |
Why?
|
Survival Rate | 2 | 2020 | 12821 | 0.060 |
Why?
|
Mass Screening | 2 | 2022 | 5445 | 0.060 |
Why?
|
Coffee | 1 | 2010 | 593 | 0.060 |
Why?
|
Social Dominance | 1 | 2005 | 39 | 0.060 |
Why?
|
Epigenomics | 2 | 2023 | 959 | 0.060 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2024 | 12 | 0.060 |
Why?
|
Veterans | 1 | 2018 | 2667 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6304 | 0.060 |
Why?
|
Beverages | 1 | 2010 | 819 | 0.060 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2024 | 58 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20680 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3851 | 0.060 |
Why?
|
Empathy | 1 | 2008 | 474 | 0.060 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2010 | 645 | 0.060 |
Why?
|
Logistic Models | 3 | 2017 | 13266 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3106 | 0.050 |
Why?
|
alpha 1-Antitrypsin | 1 | 2024 | 168 | 0.050 |
Why?
|
Proteins | 1 | 2018 | 5996 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2014 | 65223 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2014 | 2538 | 0.050 |
Why?
|
Parents | 1 | 2017 | 3590 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15881 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14745 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6601 | 0.050 |
Why?
|
Acyltransferases | 1 | 2024 | 305 | 0.050 |
Why?
|
Pakistan | 1 | 2023 | 300 | 0.050 |
Why?
|
Liver | 3 | 2023 | 7558 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10383 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2631 | 0.050 |
Why?
|
Genetic Pleiotropy | 1 | 2022 | 182 | 0.050 |
Why?
|
Arabs | 1 | 2023 | 190 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2024 | 526 | 0.050 |
Why?
|
Sitosterols | 1 | 2020 | 9 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 2066 | 0.040 |
Why?
|
Population Groups | 1 | 2021 | 209 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6960 | 0.040 |
Why?
|
Phytosterols | 1 | 2020 | 55 | 0.040 |
Why?
|
England | 1 | 2021 | 533 | 0.040 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2020 | 64 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 643 | 0.040 |
Why?
|
Pregnancy | 1 | 2022 | 30215 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2020 | 120 | 0.040 |
Why?
|
Factor X | 1 | 2019 | 64 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6941 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6893 | 0.040 |
Why?
|
Public Policy | 1 | 2024 | 551 | 0.040 |
Why?
|
Italy | 1 | 2021 | 851 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2022 | 608 | 0.040 |
Why?
|
Peptide Fragments | 2 | 2023 | 5127 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 523 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 843 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2023 | 467 | 0.040 |
Why?
|
Heart | 2 | 2024 | 4419 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2097 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2019 | 202 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 26337 | 0.040 |
Why?
|
Apoptosis | 1 | 2014 | 9512 | 0.040 |
Why?
|
Macaca mulatta | 1 | 2005 | 2341 | 0.040 |
Why?
|
Chromatin | 2 | 2022 | 2980 | 0.040 |
Why?
|
Kidney | 2 | 2023 | 7073 | 0.040 |
Why?
|
Survivors | 1 | 2008 | 2373 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2021 | 540 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2022 | 682 | 0.040 |
Why?
|
Leukocyte Rolling | 1 | 2017 | 69 | 0.040 |
Why?
|
Echocardiography | 1 | 2010 | 5042 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1013 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1366 | 0.030 |
Why?
|
Adolescent | 3 | 2022 | 88794 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 271 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2418 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2024 | 7846 | 0.030 |
Why?
|
Haplotypes | 1 | 2022 | 2728 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 614 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2017 | 370 | 0.030 |
Why?
|
Chest Pain | 1 | 2023 | 1101 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 506 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3427 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1752 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2020 | 878 | 0.030 |
Why?
|
Abdominal Fat | 1 | 2017 | 217 | 0.030 |
Why?
|
Japan | 1 | 2019 | 1415 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1738 | 0.030 |
Why?
|
Philadelphia | 1 | 2015 | 267 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1056 | 0.030 |
Why?
|
Attention | 1 | 2005 | 2415 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23588 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2023 | 3418 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 9081 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 982 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2018 | 1739 | 0.030 |
Why?
|
Up-Regulation | 2 | 2015 | 4133 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 569 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2137 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21064 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2033 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1949 | 0.030 |
Why?
|
Quality of Life | 1 | 2014 | 13466 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2643 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14445 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2879 | 0.020 |
Why?
|
Demography | 1 | 2016 | 1640 | 0.020 |
Why?
|
Gene Silencing | 1 | 2018 | 1505 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2017 | 1322 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18970 | 0.020 |
Why?
|
Decision Making | 1 | 2005 | 3955 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1497 | 0.020 |
Why?
|
Macular Degeneration | 1 | 2017 | 1001 | 0.020 |
Why?
|
Scavenger Receptors, Class B | 1 | 2010 | 83 | 0.020 |
Why?
|
Cardiology | 1 | 2021 | 1700 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3557 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3906 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3931 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 5529 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22323 | 0.020 |
Why?
|
Cardiac Output, Low | 1 | 2010 | 192 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2015 | 81505 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5594 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3447 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4255 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 572 | 0.020 |
Why?
|
Systole | 1 | 2010 | 935 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2010 | 684 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12402 | 0.020 |
Why?
|
Myocardium | 1 | 2020 | 4763 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3335 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2219 | 0.020 |
Why?
|
Electrocardiography | 1 | 2020 | 6408 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2592 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2010 | 565 | 0.020 |
Why?
|
Diuretics | 1 | 2010 | 612 | 0.020 |
Why?
|
Diet | 1 | 2023 | 8085 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7581 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3950 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2017 | 3584 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4911 | 0.010 |
Why?
|
Creatinine | 1 | 2010 | 1916 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3794 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5368 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3617 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2233 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2687 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12056 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2005 | 1993 | 0.010 |
Why?
|
Reward | 1 | 2005 | 980 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14062 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5995 | 0.010 |
Why?
|
Length of Stay | 1 | 2010 | 6485 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22349 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36542 | 0.010 |
Why?
|